Target intelligence / Profile preview

CTBP2 pseudogene 1 (CTBP2P1)

Target: CTBP2P1
Molecular classification: Other (Pseudogene)

Overview

CTBP2 pseudogene 1 (CTBP2P1) is classified as a pseudogene and does not encode a functional protein or biologically active target. It is related by sequence homology to the gene CTBP2 (C-terminal binding protein 2), which is a functional transcriptional co-repressor implicated in cancer and cellular development. However, CTBP2P1 itself is not known to be expressed, is not a drug target, and has no validated biological or pathological function.

Beyond the preview

Go deeper on CTBP2 pseudogene 1 (CTBP2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTBP2 pseudogene 1 (CTBP2P1).

Explore the full profile